Early targets of lithium in rat kidney inner medullary collecting duct include p38 and ERK1/2

Kidney International

Volumn 86, Issue 4, 2014, Pages 757-767

  Trepiccione, Francesco ^a,b   Pisitkun, Trairak ^c,d   Hoffert, Jason D ^c   Poulsen, Søren B ^a   Capasso, Giovambattista ^b   Nielsen, Søren ^a   Knepper, Mark A ^c   Fenton, Robert A ^a   Christensen, Birgitte M ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

cell and transport physiology; cell signaling; diabetes insipidus; mass spectrometry; renal cell biology

Indexed keywords

AQUAPORIN 2; AQUAPORIN 4; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; JAGGED1; LITHIUM; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; P21 ACTIVATED KINASE 2; PAXILLIN; PHOSPHOPEPTIDE; PHOSPHOPROTEIN; PROLINE; PROTEIN CDC42; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR; SERINE; SODIUM CHLORIDE; UBIQUITIN PROTEIN LIGASE NEDD4; VASODILATOR STIMULATED PHOSPHOPROTEIN; LITHIUM DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE INHIBITOR; PROTEOME;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CELL ADHESION; CELL SHAPE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FLUID INTAKE; INNER MEDULLARY COLLECTING DUCT; KIDNEY COLLECTING TUBULE; MALE; MASS SPECTROMETRY; MICTURITION; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; POLYURIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEOMICS; RAT; SIGNAL TRANSDUCTION; TIGHT JUNCTION; UPREGULATION; URINE OSMOLALITY; URINE VOLUME; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; PHOSPHORYLATION; WISTAR RAT;

ANIMALS; DIABETES INSIPIDUS, NEPHROGENIC; DOWN-REGULATION; KIDNEY TUBULES, COLLECTING; LITHIUM COMPOUNDS; MALE; MAP KINASE SIGNALING SYSTEM; MASS SPECTROMETRY; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN KINASE INHIBITORS; PROTEOME; RATS; RATS, WISTAR; UP-REGULATION;

EID: 84926162413     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.107     Document Type: Article

References (46)

1. Trepiccione F, Christensen BM. Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings. J Nephrol 2010; 23(Suppl 16): S43-S48.
2. Cogan E, Abramow M. Inhibition by lithium of the hydroosmotic action of vasopressin in the isolated perfused cortical collecting tubule of the rabbit. J Clin Invest 1986; 77: 1507-1514.
3. Pedersen RS, Bentzen H, Bech JN et al. Effect of an acute oral lithium intake on urinary Aquaporin-2 in healthy humans with and without simultaneous stimulation with hypertonic saline infusion. Scand J Clin Lab Invest 2003; 63: 181-194.
4. Nielsen J, Hoffert JD, Knepper MA et al. Proteomic analysis of lithiuminduced nephrogenic diabetes insipidus: mechanisms for aquaporin 2 down-regulation and cellular proliferation. Proc Natl Acad Sci USA 2008; 105: 3634-3639.
5. Li Y, Shaw S, Kamsteeg EJ et al. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity. J Am Soc Nephrol 2006; 17: 1063-1072.
6. Hwang GS, Yang JY, Ryu dH et al. Metabolic profiling of kidney and urine in rats with lithium-induced nephrogenic diabetes insipidus by (1)H-NMR-based metabonomics. Am J Physiol Renal Physiol 2010; 298: F461-F470.
7. Marples D, Christensen S, Christensen EI et al. Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest 1995; 95: 1838-1845.
8. Christensen BM, Marples D, Kim YH et al. Changes in cellular composition of kidney collecting duct cells in rats with lithium-induced NDI. Am J Physiol Cell Physiol 2004; 286: C952-C964.
9. Wang G, Wu WW, Zeng W et al. Label-free protein quantification using LC-coupled ion trap or FT mass spectrometry: reproducibility, linearity, and application with complex proteomes. J Proteome Res 2006; 5: 1214-1223.
10. Rao R, Zhang MZ, Zhao M et al. Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria. Am J Physiol Renal Physiol 2005; 288: F642-F649.
11. Chi X, Wang S, Huang Y et al. Roles of rho GTPases in intracellular transport and cellular transformation. Int J Mol Sci 2013; 14: 7089-7108.
12. Vlahou G, Rivero F. Rho GTPase signaling in Dictyostelium discoideum: insights from the genome. Eur J Cell Biol 2006; 85: 947-959.
13. Deakin NO, Turner CE. Paxillin comes of age. J Cell Sci 2008; 121: 2435-2444.
14. Krause M, Dent EW, Bear JE et al. Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol 2003; 19: 541-564.
15. Mulinari S, Hacker U. Rho-guanine nucleotide exchange factors during development: force is nothing without control. Small GTPases 2010; 1: 28-43.
16. Jeong HW, Jeon US, Koo BK et al. Inactivation of Notch signaling in the renal collecting duct causes nephrogenic diabetes insipidus in mice. J Clin Invest 2009; 119: 3290-3300.
17. Sampogna RV, Al-Awqati Q. Salt and pepper distribution of cell types in the collecting duct. J Am Soc Nephrol 2013; 24: 163-165.
18. Trepiccione F, Capasso G, Nielsen S et al. Evaluation of cellular plasticity in the collecting duct during recovery from lithium-induced nephrogenic diabetes insipidus. Am J Physiol Renal Physiol 2013; 305: F919-F929.
19. Pisitkun T, Jacob V, Schleicher SM et al. Akt and ERK1/2 pathways are components of the vasopressin signaling network in rat native IMCD. Am J Physiol Renal Physiol 2008; 295: F1030-F1043.
20. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
21. Ellison DH, Velazquez HE, Wright FS. Osmotic activity of dimethyl sulfoxide in the renal distal tubule. Kidney Int 1984; 26: 471-475.
22. Rinschen MM, Yu MJ, Wang G et al. Quantitative phosphoproteomic analysis reveals vasopressin V2-receptor-dependent signaling pathways in renal collecting duct cells. Proc Natl Acad Sci USA 2010; 107: 3882-3887.
23. Lu HJ, Matsuzaki T, Bouley R et al. The phosphorylation state of serine 256 is dominant over that of serine 261 in the regulation of AQP2 trafficking in renal epithelial cells. Am J Physiol Renal Physiol 2008; 295: F290-F294.
24. Moeller HB, Praetorius J, Rutzler MR et al. Phosphorylation of aquaporin-2 regulates its endocytosis and protein-protein interactions. Proc Natl Acad Sci USA 2010; 107: 424-429.
25. Nedvetsky PI, Tabor V, Tamma G et al. Reciprocal regulation of aquaporin-2 abundance and degradation by protein kinase A and p38-MAP kinase. J Am Soc Nephrol 2010; 21: 1645-1656.
26. Tamma G, Robben JH, Trimpert C et al. Regulation of AQP2 localization by S256 and S261 phosphorylation and ubiquitination. Am J Physiol Cell Physiol 2011; 300: C636-C646.
27. Jacob SW, de la Torre JC. Pharmacology of dimethyl sulfoxide in cardiac and CNS damage. Pharmacol Rep 2009; 61: 225-235.
28. Levine S, Saltzman A, Katof B et al. Prevention of lithium nephrotoxicity in a novel one-hour model in rats. Psychopharmacology (Berl) 1998; 138: 34-39.
29. Diaz D, Allamneni K, Tarrant JM et al. Phosphorous dysregulation induced by MEK small molecule inhibitors in the rat involves blockade of FGF-23 signaling in the kidney. Toxicol Sci 2012; 125: 187-195.
30. Badger AM, Bradbeer JN, Votta B et al. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 1996; 279: 1453-1461.
31. Lyubynska N, Gorman MF, Lauchle JO et al. A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice. Sci Transl Med 2011; 3: 76ra27.
32. Stokes JB, Grupp C, Kinne RK. Purification of rat papillary collecting duct cells: functional and metabolic assessment. Am J Physiol 1987; 253: F251-F262.
33. Pisitkun T, Bieniek J, Tchapyjnikov D et al. High-throughput identification of IMCD proteins using LC-MS/MS. Physiol Genomics 2006; 25: 263-276.
34. Tanner S, Shu H, Frank A et al. InsPecT: identification of posttranslationally modified peptides from tandem mass spectra. Anal Chem 2005; 77: 4626-4639.
35. Yates JR III, Morgan SF, Gatlin CL et al. Method to compare collisioninduced dissociation spectra of peptides: potential for library searching and subtractive analysis. Anal Chem 1998; 70: 3557-3565.
36. Geer LY, Markey SP, Kowalak JA et al. Open mass spectrometry search algorithm. J Proteome Res 2004; 3: 958-964.
37. Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods 2007; 4: 207-214.
38. Hoffert JD, Pisitkun T, Saeed F et al. Dynamics of the G protein-coupled vasopressin V2 receptor signaling network revealed by quantitative phosphoproteomics. Mol Cell Proteomics 2012; 11: M111.
39. Zhao B, Pisitkun T, Hoffert JD et al. CPhos: a program to calculate and visualize evolutionarily conserved functional phosphorylation sites. Proteomics 2012; 12: 3299-3303.
40. Schwartz D, Gygi SP. An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat Biotechnol 2005; 23: 1391-1398.
41. Szklarczyk D, Franceschini A, Kuhn M et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 2011; 39: D561-D568.
42. Pavlopoulos GA, Hooper SD, Sifrim A et al. Medusa: A tool for exploring and clustering biological networks. BMC Res Notes 2011; 4: 384.
43. Christensen BM, Zelenina M, Aperia A et al. Localization and regulation of PKA-phosphorylated AQP2 in response to V(2)-receptor agonist/ antagonist treatment. Am J Physiol Renal Physiol 2000; 278: F29-F42.
44. Hoffert JD, Nielsen J, Yu MJ et al. Dynamics of aquaporin-2 serine-261 phosphorylation in response to short-term vasopressin treatment in collecting duct. Am J Physiol Renal Physiol 2007; 292: F691-F700.
45. Hoffert JD, Fenton RA, Moeller HB et al. Vasopressin-stimulated increase in phosphorylation at Ser269 potentiates plasma membrane retention of aquaporin-2. J Biol Chem 2008; 283: 24617-24627.
46. Christensen BM, Zuber AM, Loffing J et al. {alpha}ENaC-mediated lithium absorption promotes nephrogenic diabetes insipidus. J Am Soc Nephrol 2011; 22: 253-261.